Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 appears on the page header, replacing the previous Revision: v3.3.1. This is a minor update with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedA clarifying line stating that publications are automatically filled from PubMed was added to the Publications section, and the footer revision now shows v3.3.1. The previous PubMed note and the old v3.2.0 revision text were removed.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the government funding lapse notice and related operating-status information from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedNo substantive changes detected between the old and new screenshots of the ClinicalTrials.gov study page; content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%

- Check71 days agoChange DetectedNew contact details and an updated revision version (v3.1.0) were added, replacing the previous v3.0.2.SummaryDifference0.0%

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.